BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21163886)

  • 61. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
    Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
    Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate.
    Warin R; Chambers WH; Potter DM; Singh SV
    Cancer Res; 2009 Dec; 69(24):9473-80. PubMed ID: 19934325
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells.
    Taliaferro-Smith L; Nagalingam A; Zhong D; Zhou W; Saxena NK; Sharma D
    Oncogene; 2009 Jul; 28(29):2621-33. PubMed ID: 19483724
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells.
    McMurtry V; Simeone AM; Nieves-Alicea R; Tari AM
    Clin Exp Metastasis; 2009; 26(3):197-204. PubMed ID: 19112600
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor.
    Saxena NK; Taliaferro-Smith L; Knight BB; Merlin D; Anania FA; O'Regan RM; Sharma D
    Cancer Res; 2008 Dec; 68(23):9712-22. PubMed ID: 19047149
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells.
    Xiao D; Powolny AA; Singh SV
    J Biol Chem; 2008 Oct; 283(44):30151-63. PubMed ID: 18768478
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metastasis: a therapeutic target for cancer.
    Steeg PS; Theodorescu D
    Nat Clin Pract Oncol; 2008 Apr; 5(4):206-19. PubMed ID: 18253104
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bioactive food components and cancer risk reduction.
    Stan SD; Kar S; Stoner GD; Singh SV
    J Cell Biochem; 2008 May; 104(1):339-56. PubMed ID: 18092339
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
    Vona-Davis L; Rose DP
    Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status.
    Ray A; Nkhata KJ; Cleary MP
    Int J Oncol; 2007 Jun; 30(6):1499-509. PubMed ID: 17487372
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.
    Schäffler A; Schölmerich J; Buechler C
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):345-54. PubMed ID: 17377617
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.
    Saxena NK; Sharma D; Ding X; Lin S; Marra F; Merlin D; Anania FA
    Cancer Res; 2007 Mar; 67(6):2497-507. PubMed ID: 17363567
    [TBL] [Abstract][Full Text] [Related]  

  • 73. leptin-induced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3.
    Saxena NK; Vertino PM; Anania FA; Sharma D
    J Biol Chem; 2007 May; 282(18):13316-25. PubMed ID: 17344214
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak.
    Xiao D; Vogel V; Singh SV
    Mol Cancer Ther; 2006 Nov; 5(11):2931-45. PubMed ID: 17121941
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of leptin antagonists and their potential use in experimental biology and medicine.
    Gertler A
    Trends Endocrinol Metab; 2006 Nov; 17(9):372-8. PubMed ID: 17010639
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2).
    Gonzalez RR; Cherfils S; Escobar M; Yoo JH; Carino C; Styer AK; Sullivan BT; Sakamoto H; Olawaiye A; Serikawa T; Lynch MP; Rueda BR
    J Biol Chem; 2006 Sep; 281(36):26320-8. PubMed ID: 16825198
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways.
    Sharma D; Saxena NK; Vertino PM; Anania FA
    Endocr Relat Cancer; 2006 Jun; 13(2):629-40. PubMed ID: 16728588
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Molecular links between obesity and breast cancer.
    Lorincz AM; Sukumar S
    Endocr Relat Cancer; 2006 Jun; 13(2):279-92. PubMed ID: 16728564
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Leptin receptor expression and cell signaling in breast cancer.
    Frankenberry KA; Skinner H; Somasundar P; McFadden DW; Vona-Davis LC
    Int J Oncol; 2006 Apr; 28(4):985-93. PubMed ID: 16525650
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.